首页> 外文期刊>Japanese Journal of Ophthalmology >Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study.
【24h】

Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study.

机译:局部使用尼地洛尔或噻吗洛尔治疗的正压性青光眼患者视野丧失:尼帕地洛-替莫洛尔研究的亚组和亚视野分析。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To estimate the deterioration rates of visual field loss in Japanese normal-tension glaucoma (NTG) patients under either topical nipradilol or timolol, and to explore intergroup differences in the treatment results. METHODS: A total of 146 NTG patients with mild to moderate damage were randomized to either nipradilol or timolol and followed for 3 years with a periodic comprehensive ophthalmological visual field examination (30-2 Humphrey perimeter program) every 6 months (the Nipradilol-Timolol Study). The time course of mean deviation (MD), the average total deviation (TD(mean)) in four subfields, and the corrected pattern standard deviation (CPSD) were compared between the two groups using regression analysis with a linear mixed effect model. RESULTS: The estimated slope for MD (dB/year) was -0.03 in the nipradilol and -0.05 in the timolol group (P > 0.4). In both groups, TD(mean) in the superior-central subfield and CPSD showed significant changes (-0.3 and 0.2-0.3, P
机译:目的:评估局部使用尼地洛尔或噻吗洛尔治疗的日本正常血压青光眼(NTG)患者视野丧失的恶化率,并探讨治疗结果之间的群体差异。方法:将总共146例轻度至中度损害的NTG患者随机分为尼泊洛尔或替莫洛尔,每6个月进行3年定期的全面眼科视野检查(30-2汉弗莱视野检查)(Nipradilol-Timolol研究) )。使用线性混合效应模型进行回归分析,比较了两组之间的平均偏差(MD)的时程,四个子字段的平均总偏差(TD(mean))以及校正模式标准偏差(CPSD)。结果:尼帕地洛的MD估计斜率(dB /年)为-0.03,替莫洛尔组的估计斜率为-0.05(P> 0.4)。在两组中,中上子区域的TD(平均值)和CPSD均显示出显着变化(-0.3和0.2-0.3,P <或= 0.001)。在早期视野丧失的患者或小于40岁的患者中,尼普地洛组的某些视野参数的恶化往往比噻吗洛尔组要慢。结论:在NTG患者单用尼普洛尔或替莫洛尔的3年单药治疗期间,仅中央上位子区和CPSD的TD(平均值)发生了显着变化,而组间无任何差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号